Chai Bio is a privately held company tracked for investment-relevant business and technology developments.
This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.
Chai Bio is a leading player in AI protein design and has already translated its models into a significant commercial deal with Eli Lilly, validating the near-term revenue potential of AI-driven drug discovery.